Agenerase Trademark Details

Agenerase was registered on Tuesday, February 8, 2000 and is currently owned by Viiv Healthcare Company under the registration number 2317064 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 13 years ago on Friday, September 10, 2010, according to the United State Patent & Trademark Office
Word Mark Agenerase
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Viiv Healthcare Company of Wilmington, DE

View all trademarks for Viiv Healthcare Company
Other Trademarks for Viiv Healthcare Company

Previous Owners

Smithkline Beecham Corporation of Philadelphia, PA

View all trademarks for Smithkline Beecham Corporation
Other Trademarks for Smithkline Beecham Corporation

Glaxo Group Limited

View all trademarks for Glaxo Group Limited
Serial Number 75366369
Registration Number 2317064
Status Date Friday, September 10, 2010
Filing Date Friday, September 10, 2010
Registration Date Tuesday, February 8, 2000
Attorney Diane Fry Maginnis
Domestic Representative Diane Fry Maginnis

Correspondent

Diane Fry Maginnis
GlaxoSmithKline
LGTM, C.3157.3D
Five Moore Drive
Research Triangle Park NC 27709

Case File Statements

Goods & Services Anti-Viral Pharmaceutical Preparations and Substances

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, September 10, 2010
First Use Anywhere Monday, April 26, 1999
First Use In Commerce Monday, April 26, 1999
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.